Page 3 - Diabetes In India

Eli Lilly launches blockbuster anti-obesity drug Mounjaro in India. Prices here

Eli Lilly's much-anticipated drug for diabetes and obesity, that competes with Ozempic globally, is now in India. Here's what you need to know

Morepen Labs shares skyrocket 12% on rolling out 'Empamore'; details here

The uptick in the Morepen Labs share came after the company announced that it has rolled out 'Empamore.'

Glenmark launches Empagliflozin for diabetes in India under Glempa brand

Glenmark Pharmaceuticals on Wednesday said it has launched a medication for glycemic control and weight-loss for diabetes patients. The Mumbai-based drug firm has launched Empagliflozin, a widely recognised SGLT2 inhibitor, under the brand name Glempa (Empagliflozin 10/25 mg), along with its fixed-dose combinations (FDCs)'?Glempa-L (Empagliflozin 10/25 mg + Linagliptin 5 mg) and Glempa-M (Empagliflozin 12.5 mg + Metformin 500/1000 mg). The medications are designed to improve glycemic control in adults with type 2 diabetes mellitus while also reducing cardiovascular outcomes in patients with cardiovascular risk. Studies have demonstrated several benefits of Empagliflozin, including effectively improving glycemic control, supporting weight-loss, and reducing cardiovascular-renal risks in patients with type 2 diabetes mellitus. Empagliflozin has also demonstrated benefits in heart failure patients by lowering the cardiovascular death or hospitalisation. "The launch of Glempa range ..

ICMR sets up India's first diabetes biobank in Chennai for research

The country's first diabetes biobank, a repository of population-based biological samples aimed at supporting scientific research, has been established in Chennai by the Indian Council of Medical Research (ICMR) in collaboration with the Madras Diabetes Research Foundation (MDRF). The biobank set up at the MDRF, Chennai aims to gather, process, store and distribute biospecimens to assist scientific studies with the permission of the ICMR. The biobank will facilitate advanced research on the causes of diabetes, the variations of the Indian type of diabetes and related disorders, said Dr V Mohan, chairman of the MDRF and Dr Mohan's Diabetes Specialities Centre. The biobank has blood samples from two ICMR-funded studies -- the ICMR-?India Diabetes (ICMR-?INDIAB) study conducted in all states and Union territories in phases from 2008 to 2020 and the "Registry of people with diabetes in India at a young age at the onset", which was launched in 2006 and is still ongoing. A plethora of bl

Diabetes health insurance in India: Plans, coverage, and costs explained

Diabetes cannot prevent you from getting a policy. You must disclose it as a pre-existing illness, but insurers cannot deny cover solely on this basis

World Diabetes Day 2024: Theme, history and best winter foods for patients

Every year on November 14, we observe the World Diabetes Day (WDD) to increase awareness of diabetes, a chronic condition that affects millions of people worldwide

How fried and processed foods are fuelling India's diabetes epidemic

Indian diets, traditionally rich in whole grains, fruits, and vegetables, have shifted towards processed, fried, and sugar-laden foods, according to a recent government-backed study

Late-night sleepers face 50% greater risk of developing Type 2 diabetes

Staying up late increases Type 2 diabetes risk by nearly 50 per cent and is associated with higher BMI, larger waist circumference, and more visceral and liver fat

Need to face up to junk food crisis as study shows 23% Indians overweight

Indians need simple, easy-to-understand, and prominent warning labels, so that their better natures are given a chance to overtake their impulses

Can diabetes be cured? Chinese doctors claim breakthrough with cell therapy

A 59-year-old man with type 2 diabetes received an innovative cell transplant and has been insulin-free and off medication for 33 months, offering hope to other diabetes patients

New oral diabetes and obesity drug sale doubles in India amid demand surge

The sales of Novo Nordisk's Rybelsus tablet, used for diabetes treatment and weight reduction, more than doubled to Rs 363 crore this year from Rs 147 crore last year

Fix your gut health to prevent diabetes, hypertension, tells study

Findings based on research conducted by microbiome-based company Leucine Rich Bio using its flagship technology BugSpeaks

Besides Covid-19, diabetes and renal disease reduce Indian lifespan

Covid-19 was the leading cause of death in India, as per the study. The age-standardised rate of deaths for both males and females was 156.8 per 100,000 population

Sun Pharma, Bayer partner for diabetes-linked kidney disease medicine

Diabetes is an epidemic in India, with nearly 100 million Indians suffering from it. Diabetes has also been identified as the leading cause of chronic kidney disease in India

Glenmark Pharmaceuticals launches antidiabetic drug 'Lirafit' in India

Glenmark Pharmaceuticals on Wednesday said it has launched a biosimilar of the popular antidiabetic drug, Liraglutide in India. The drug is being marketed under the brand name Lirafit following the approval from the Drug Controller General of India (DCGI), the company said in a statement. It is priced at around Rs 100 for a standard dose of 1.2mg (per day) and will lower the cost of therapy by approximately 70 per cent, the company claimed. Lirafit will be available only under prescription. "Clinical trials have shown that it helps improve glycemic control in adult type 2 diabetes mellitus patients along with atherosclerotic cardiovascular diseases (ASCVD) and obesity," Glenmark Pharmaceuticals President and Business Head India Formulations, Alok Malik said. Liraglutide has also proven to have a positive impact on cardiac and renal safety outcomes among patients in clinical trials, making it an effective choice of treatment for patients with type 2 diabetes mellitus, he added. "W

50% surge in diabetes in individuals under 40 yrs of age, say experts

India is often dubbed as the diabetic capital of the world where nearly 11 per cent of the population is grappling with the disease

Zydus gets USFDA nod for Zituvimet for type-2 diabetes mellitus treatment

The company said that Zituvimet has undergone quality testing for Nitrosamines and potential genotoxic impurities according to current FDA standards

1 in 5 'healthy' adults have glucose metabolism of a prediabetic: Study

About 20 per cent or one in five adults considered healthy by medical standards, have glucose metabolism similar to those with prediabetes, finds an alarming study

Approx 1 person in 20 is diabetic, 3-5% of new cases linked to Covid: Study

The findings, published in JAMA Network Open, showed that men were more likely to develop diabetes than women

How diabetes-specific insurance plans offer coverage and benefits

Policies assist those already suffering from the disease and most cost only around 20% more